Company Filing History:
1 out of 1,247 
1 out of 5,463 
Years Active: 2019
Title: The Innovative Mind of Cecelia Brewington in Cancer Detection
Introduction: Cecelia Brewington, an accomplished inventor based in Plano, TX, has made significant strides in the field of medical imaging. With a focus on computed tomography perfusion (CTP), her innovative work aims to improve cancer detection and treatment through advanced methodologies.
Latest Patents: Cecelia Brewington holds a patented invention titled "Computed tomography perfusion (CTP) method and apparatus using blood flow for discriminating types of cancer." This patent outlines a method to identify cancerous lesions with genetic mutations, particularly in lung cancer. By utilizing blood flow as a biomarker, her approach distinguishes between primary and metastatic lesions. Notably, her method defines a threshold for identifying mutations based on pulmonary blood flow, showcasing a sensitivity of 100% and a specificity of 62%. The detailed analysis employs multivariable statistics that consider both CTP values and relevant patient information, presenting a groundbreaking approach to cancer diagnostics.
Career Highlights: Brewington's career has been defined by her work with notable companies. She has collaborated with Canon Medical Systems Corporation, where her research has had a profound impact on medical imaging technologies. Additionally, her academic tenure at the Massachusetts Institute of Technology has enriched her expertise, allowing her to contribute to significant advancements in the field.
Collaborations: Throughout her journey, Cecelia Brewington has worked alongside esteemed colleagues, including Eugene A Mensah and Erin Angel. Their collaborative efforts have furthered her research and expanded the reach of her innovative methodologies in cancer detection.
Conclusion: Cecelia Brewington represents a remarkable figure in the realm of medical innovation. Her patented work on computed tomography perfusion stands as a testament to her dedication to enhancing cancer diagnostics. As she continues to push the boundaries of medical imaging, her contributions hold the promise of improving patient outcomes in the fight against cancer.